The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism – or inverse agonism – as potential obesity treatment and other therapeutic use
Titel:
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism – or inverse agonism – as potential obesity treatment and other therapeutic use
Auteur:
Xie, S. Furjanic, M. A. Ferrara, J. J. McAndrew, N. R. Ardino, E. L. Ngondara, A. Bernstein, Y. Thomas, K. J. Kim, E. Walker, J. M. Nagar, S. Ward, S. J. Raffa, R. B.